Addition of a low-profile device to the Surmodics Pounce™ thrombectomy platform allows for efficient clot removal in peripheral arteries ranging from 2 mm to 4 mm, such as those found below the knee ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the ...
Endologix said Tuesday it has bought a device for removing clots from peripheral arteries from Surmodics for an undisclosed amount. The product, Pounce, is a catheter system for the mechanical, ...
Hosted on MSN
Surmodics launches Pounce XL thrombectomy system
Surmodics has initiated a full commercial release of its Pounce XL thrombectomy system for acute or chronic clot removal. Available through a limited market release since January 2025, Pounce XL ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced successful early clinical use of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results